Patents by Inventor Eric A. Marcotulli

Eric A. Marcotulli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nicotinamide riboside for use in treating or preventing liver damage
    Patent number: 12128060
    Abstract: Provided herein are methods and compositions related to treating and/or preventing liver related diseases and disorders and for improving liver health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Grant
    Filed: June 16, 2022
    Date of Patent: October 29, 2024
    Assignee: Elysium Health, Inc.
    Inventors: Ryan Dellinger, Santiago Roel Santos, Eric A. Marcotulli, Daniel A. Alminana, Mark Morris, Leonard Pershing Guarente
  • Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders
    Patent number: 12109206
    Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating skin disorders, and methods of treating skin disorders using these compositions and their equivalents are described. The skin disorders that are treated using these compositions or methods include sun exposure-related skin disorders, inflammatory skin disorders, autoimmune disease-related skin disorders and cancer-related skin disorders. In one embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene are prepared as oral formulations.
    Type: Grant
    Filed: July 25, 2022
    Date of Patent: October 8, 2024
    Assignee: Elysium Health, Inc.
    Inventors: Eric A. Marcotulli, Daniel A. Alminana, Paul M. Bowen
  • NICOTINAMIDE RIBOSIDE AND PTEROSTILBENE COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN DISORDERS
    Publication number: 20220362233
    Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating skin disorders, and methods of treating skin disorders using these compositions and their equivalents are described. The skin disorders that are treated using these compositions or methods include sun exposure-related skin disorders, inflammatory skin disorders, autoimmune disease-related skin disorders and cancer-related skin disorders. In one embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene are prepared as oral formulations.
    Type: Application
    Filed: July 25, 2022
    Publication date: November 17, 2022
    Inventors: Eric A. Marcotulli, Daniel A. Alminana, Paul M. Bowen
  • NICOTINAMIDE RIBOSIDE FOR USE IN TREATING OR PREVENTING LIVER DAMAGE
    Publication number: 20220305040
    Abstract: Provided herein are methods and compositions related to treating and/or preventing liver related diseases and disorders and for improving liver health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: June 16, 2022
    Publication date: September 29, 2022
    Inventors: Ryan Dellinger, Santiago Roel Santos, Eric A. Marcotulli, Daniel A. Alminana, Mark Morris, Leonard Pershing Guarente
  • Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders
    Patent number: 11426398
    Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating skin disorders, and methods of treating skin disorders using these compositions and their equivalents are described. The skin disorders that are treated using these compositions or methods include sun exposure-related skin disorders, inflammatory skin disorders, autoimmune disease-related skin disorders and cancer-related skin disorders. In one embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene are prepared as oral formulations.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: August 30, 2022
    Assignee: Elysium Health, Inc.
    Inventors: Eric A. Marcotulli, Daniel A. Alminana, Paul M. Bowen
  • Treating and preventing kidney damage
    Patent number: 11129843
    Abstract: Provided herein are methods and compositions related to treating and/or preventing kidney related diseases and disorders, treating and/or preventing acute kidney injury, and for improving kidney health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: September 28, 2021
    Assignee: Elysium Health, Inc.
    Inventors: Eric A. Marcotulli, Daniel A. Alminana, Leonard Pershing Guarente, Ryan Dellinger, Mark Morris
  • PREVENTION AND TREATMENT OF TDP-43 ASSOCIATED DISEASES
    Publication number: 20200330497
    Abstract: Provided herein are methods and compositions related to treating and/or preventing diseases or disorder associated with cytoplasmic accumulation of TDB-43 by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: October 19, 2018
    Publication date: October 22, 2020
    Inventors: Eric A. Marcotulli, Dan Alminana, Mark Morris, Ryan Dellinger
  • METHODS AND COMPOSITIONS FOR IMPROVING SLEEP
    Publication number: 20200085849
    Abstract: Provided herein are methods and compositions related to treating and/or preventing sleep disorders and for improving sleep health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: May 18, 2018
    Publication date: March 19, 2020
    Inventors: Eric A. Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris
  • TREATING AND PREVENTING KIDNEY DAMAGE
    Publication number: 20200069711
    Abstract: Provided herein are methods and compositions related to treating and/or preventing kidney related diseases and disorders, treating and/or preventing acute kidney injury, and for improving kidney health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: April 23, 2018
    Publication date: March 5, 2020
    Inventors: Eric A. Marcotulli, Daniel A. Alminana, Leonard Pershing Guarente, Ryan Dellinger, Mark Morris